Cha University
Clinical trials sponsored by Cha University, explained in plain language.
-
New hope for tough liver cancers: trial tests targeted drug combo
Disease control Not yet recruitingThis study is for adults with advanced liver cancer (HCC) that has worsened after their first immunotherapy treatment. It will test if adding a new, liver-targeted oral drug called fostrox to the standard drug lenvatinib is more effective and safe than using lenvatinib alone. Abo…
Phase: PHASE2 • Sponsor: CHA University • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
Simple blood test could replace risky biopsies for bile duct cancer
Knowledge-focused Not yet recruitingThis study is testing whether a simple blood test can find specific genetic changes in advanced bile duct cancer, which is often hard to biopsy. Researchers will enroll 100 patients to see if the blood test results match traditional tissue tests and if they can help predict how w…
Sponsor: CHA University • Aim: Knowledge-focused
Last updated Mar 12, 2026 13:51 UTC